Further processing options
The Raf kinase inhibitor BAY 43-9006 reduces cellular uptake of platinum compounds and cytotoxicity in human colorectal carcinoma cell lines
Saved in:
Journal Title: | Anti-Cancer Drugs |
---|---|
Authors and Corporations: | , , , , , , |
In: | Anti-Cancer Drugs, 16, 2005, 2, p. 129-136 |
Type of Resource: | E-Article |
Language: | English |
published: |
Ovid Technologies (Wolters Kluwer Health)
|
Subjects: |